review article | Q7318358 |
scholarly article | Q13442814 |
P356 | DOI | 10.3389/FPHAR.2016.00244 |
P8608 | Fatcat ID | release_nwo7utcmobfutdgixxd575trnu |
P3181 | OpenCitations bibliographic resource ID | 4095129 |
P932 | PMC publication ID | 4982242 |
P698 | PubMed publication ID | 27570510 |
P2093 | author name string | Amnani Aminuddin | |
Pei Yuen Ng | |||
P2860 | cites work | Expression of the cancer stem cell markers CD44v6 and ABCG2 in tongue cancer: effect of neoadjuvant chemotherapy on local recurrence | Q87247439 |
Cancer stem cells in head and neck squamous cell carcinoma | Q87898094 | ||
Head inducer Dickkopf-1 is a ligand for Wnt coreceptor LRP6 | Q24291433 | ||
A noncanonical Frizzled2 pathway regulates epithelial-mesenchymal transition and metastasis | Q24307454 | ||
Tankyrase inhibition stabilizes axin and antagonizes Wnt signalling | Q24316697 | ||
The Wnt receptor FZD1 mediates chemoresistance in neuroblastoma through activation of the Wnt/beta-catenin pathway | Q24322825 | ||
Wnt/beta-catenin signaling: components, mechanisms, and diseases | Q24630938 | ||
Prospective identification of tumorigenic breast cancer cells | Q24683474 | ||
Targeting the Wnt pathway in human cancers: therapeutic targeting with a focus on OMP-54F28 | Q26991723 | ||
Molecular mechanisms of epithelial-mesenchymal transition | Q27013743 | ||
Cancer statistics, 2010 | Q27860525 | ||
Wnt signaling and cancer | Q27860871 | ||
Stem cells, cancer, and cancer stem cells | Q27860878 | ||
Human acute myeloid leukemia is organized as a hierarchy that originates from a primitive hematopoietic cell | Q27861001 | ||
The Wnt signaling pathway in development and disease | Q27861019 | ||
Identification of a cancer stem cell in human brain tumors | Q28131688 | ||
Side population in oral squamous cell carcinoma possesses tumor stem cell phenotypes | Q39888605 | ||
Niche-mediated control of human embryonic stem cell self-renewal and differentiation | Q40065333 | ||
Transactivation of the multidrug resistance 1 gene by T-cell factor 4/beta-catenin complex in early colorectal carcinogenesis | Q40855199 | ||
NLK positively regulates Wnt/β-catenin signalling by phosphorylating LEF1 in neural progenitor cells | Q42116541 | ||
A basal-cell-like compartment in head and neck squamous cell carcinomas represents the invasive front of the tumor and is expressing MMP-9. | Q42464998 | ||
Expression of matrix metalloproteinase 1, matrix metalloproteinase 2, and matrix metalloproteinase 9 in carcinoma of the head and neck. | Q44197100 | ||
Stem cell researchers find their niche. | Q50778452 | ||
Inhibition of protein-protein interactions: The discovery of druglike β-catenin inhibitors by combining virtual and biophysical screening | Q57937295 | ||
Inhibiting the Wnt Signaling Pathway with Small Molecules | Q58455372 | ||
Recent advances in head and neck cancer | Q81950649 | ||
All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway | Q84234192 | ||
AXIN1 mutations in hepatocellular carcinomas, and growth suppression in cancer cells by virus-mediated transfer of AXIN1 | Q28145752 | ||
Reduction of beta-catenin/T-cell transcription factor signaling by aspirin and indomethacin is caused by an increased stabilization of phosphorylated beta-catenin | Q28196484 | ||
Effect of aspirin on the Wnt/beta-catenin pathway is mediated via protein phosphatase 2A | Q28199885 | ||
Wnt and frizzled receptors as potential targets for immunotherapy in head and neck squamous cell carcinomas | Q28202829 | ||
Normal stem cells and cancer stem cells: the niche matters | Q28237647 | ||
Identification and expansion of the tumorigenic lung cancer stem cell population | Q28259332 | ||
Expression and activity of P-glycoprotein, a multidrug efflux pump, in human hematopoietic stem cells | Q28275578 | ||
Identification of pancreatic cancer stem cells | Q28286997 | ||
Mutations of chromosome 5q21 genes in FAP and colorectal cancer patients | Q28300256 | ||
Wnt signalling and the mechanistic basis of tumour development | Q28301804 | ||
Both canonical and non-canonical Wnt signaling independently promote stem cell growth in mammospheres | Q28540692 | ||
A role for Wnt signalling in self-renewal of haematopoietic stem cells | Q28592213 | ||
Prospective identification of tumorigenic prostate cancer stem cells | Q29547859 | ||
WNT signalling pathways as therapeutic targets in cancer | Q29615666 | ||
Loss of E-cadherin promotes metastasis via multiple downstream transcriptional pathways | Q29615855 | ||
Caught up in a Wnt storm: Wnt signaling in cancer | Q29617494 | ||
Wnt activity defines colon cancer stem cells and is regulated by the microenvironment | Q29618024 | ||
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma | Q29620604 | ||
Applying the principles of stem-cell biology to cancer | Q29622827 | ||
Distinct pattern of expression of differentiation and growth-related genes in squamous cell carcinomas of the head and neck revealed by the use of laser capture microdissection and cDNA arrays | Q30891320 | ||
Characterization of side populations in HNSCC: highly invasive, chemoresistant and abnormal Wnt signaling | Q33631227 | ||
GSK3: a multifaceted kinase in Wnt signaling | Q33712410 | ||
Evidence for epithelial-mesenchymal transition in cancer stem cells of head and neck squamous cell carcinoma | Q33815175 | ||
Stem cells: a new lease on life | Q33824741 | ||
An updated overview on Wnt signaling pathways: a prelude for more | Q34122601 | ||
Targeting miRNAs involved in cancer stem cell and EMT regulation: An emerging concept in overcoming drug resistance. | Q34208986 | ||
Canonical and noncanonical Wnts use a common mechanism to activate completely unrelated coreceptors. | Q34289010 | ||
Updating the Wnt pathways. | Q34360489 | ||
Results of a phase I pilot clinical trial examining the effect of plant-derived resveratrol and grape powder on Wnt pathway target gene expression in colonic mucosa and colon cancer | Q34418424 | ||
Wnt pathway activity in breast cancer sub-types and stem-like cells | Q34826223 | ||
A stem cell molecular signature: are there hallmark properties that are shared by all stem cells? | Q35191755 | ||
Wnt signaling and the regulation of stem cell function | Q35941839 | ||
Wnts are dispensable for differentiation and self-renewal of adult murine hematopoietic stem cells. | Q36137248 | ||
Wnt addiction of genetically defined cancers reversed by PORCN inhibition | Q36292664 | ||
The Wnt5A/protein kinase C pathway mediates motility in melanoma cells via the inhibition of metastasis suppressors and initiation of an epithelial to mesenchymal transition. | Q36489436 | ||
Epithelial to mesenchymal transition in head and neck squamous cell carcinoma | Q36652148 | ||
Mining the Wnt pathway for cancer therapeutics | Q36670448 | ||
Honokiol Eliminates Human Oral Cancer Stem-Like Cells Accompanied with Suppression of Wnt/ β -Catenin Signaling and Apoptosis Induction | Q36801771 | ||
WNT signaling pathway and stem cell signaling network | Q36883377 | ||
Mechanisms that mediate stem cell self-renewal and differentiation | Q36890172 | ||
Understanding and targeting cancer stem cells: therapeutic implications and challenges | Q36907405 | ||
The first five years of the Wnt targetome | Q37045334 | ||
The cell-cell adhesion molecule E-cadherin. | Q37251750 | ||
Disruption of E-cadherin by matrix metalloproteinase directly mediates epithelial-mesenchymal transition downstream of transforming growth factor-beta1 in renal tubular epithelial cells. | Q37278443 | ||
Targeting Wnt-driven cancer through the inhibition of Porcupine by LGK974. | Q37395251 | ||
c-Myc controls the balance between hematopoietic stem cell self-renewal and differentiation | Q37620912 | ||
Targeting Wnt signaling: can we safely eradicate cancer stem cells? | Q37763415 | ||
New avenues to target Wnt/β-catenin signaling | Q37812683 | ||
Targeting cancer stem cells by inhibiting Wnt, Notch, and Hedgehog pathways | Q37820099 | ||
Drug discovery approaches to target Wnt signaling in cancer stem cells | Q37840943 | ||
Cancer stem cells hypothesis and stem cells in head and neck cancers | Q37971247 | ||
The role of canonical WNT signaling pathway in oral carcinogenesis: a comprehensive review. | Q37991676 | ||
Cancer stem cells accountability in progression of head and neck squamous cell carcinoma: the most recent trends! | Q38201473 | ||
A role for cancer stem cells in therapy resistance: cellular and molecular mechanisms | Q38222546 | ||
Cancer stem cells and stemness markers in oral squamous cell carcinomas. | Q38265452 | ||
Wnt/β-catenin signalling maintains self-renewal and tumourigenicity of head and neck squamous cell carcinoma stem-like cells by activating Oct4. | Q38437805 | ||
Targeting Wnt signaling in colorectal cancer. A Review in the Theme: Cell Signaling: Proteins, Pathways and Mechanisms | Q38569786 | ||
What are stem cells and how are they controlled? | Q38682067 | ||
Wnt-C59 arrests stemness and suppresses growth of nasopharyngeal carcinoma in mice by inhibiting the Wnt pathway in the tumor microenvironment. | Q38874181 | ||
Wnt signaling regulates the stemness of lung cancer stem cells and its inhibitors exert anticancer effect on lung cancer SPC-A1 cells | Q38904614 | ||
Cancer stem-like cells from head and neck cancers are chemosensitized by the Wnt antagonist, sFRP4, by inducing apoptosis, decreasing stemness, drug resistance and epithelial to mesenchymal transition | Q38967885 | ||
Functionalized curcumin analogs as potent modulators of the Wnt/β-catenin signaling pathway. | Q39055169 | ||
Emodin represses TWIST1-induced epithelial-mesenchymal transitions in head and neck squamous cell carcinoma cells by inhibiting the β-catenin and Akt pathways | Q39071189 | ||
Pharmacological inhibition of the Wnt acyltransferase PORCN prevents growth of WNT-driven mammary cancer. | Q39236918 | ||
Isolation and characterization of cancer stem-like side population cells in human oral cancer cells | Q39506627 | ||
Cancer stem cell-like cells from a single cell of oral squamous carcinoma cell lines | Q39587991 | ||
Cancer stem cell traits in squamospheres derived from primary head and neck squamous cell carcinomas. | Q39618664 | ||
Involvement of the Wnt-β-catenin pathway in invasion and migration of oral squamous carcinoma cells | Q39650570 | ||
Inhibition of Wnt signaling pathway decreases chemotherapy-resistant side-population colon cancer cells. | Q39677112 | ||
Antitumor activity of natural compounds, curcumin and PKF118-310, as Wnt/β-catenin antagonists against human osteosarcoma cells. | Q39803672 | ||
Promoter demethylation of WIF-1 by epigallocatechin-3-gallate in lung cancer cells. | Q39837569 | ||
P407 | language of work or name | English | Q1860 |
P921 | main subject | head and neck squamous cell carcinoma | Q18348812 |
P304 | page(s) | 244 | |
P577 | publication date | 2016-01-01 | |
P1433 | published in | Frontiers in Pharmacology | Q2681208 |
P1476 | title | Promising Druggable Target in Head and Neck Squamous Cell Carcinoma: Wnt Signaling | |
P478 | volume | 7 |
Q92591200 | Comparative Gene Expression Profiling of Tobacco-Associated HPV-Positive versus Negative Oral Squamous Carcinoma Cell Lines |
Q91829064 | Differential Expression And Effects Of Peroxiredoxin-6 On Drug Resistance And Cancer Stem Cell-Like Properties In Non-Small Cell Lung Cancer |
Q58197289 | Functional and genomic analyses reveal therapeutic potential of targeting β-catenin/CBP activity in head and neck cancer |
Q92978098 | Gene-Related Response of Basal Cell Carcinoma to Biologic Treatment with Vismodegib |
Q91827368 | Identification of Targetable Pathways in Oral Cancer Patients via Random Forest and Chemical Informatics |
Q52584421 | Immunological Approaches Towards Cancer and Inflammation: A Cross Talk. |
Q57069810 | Knockdown of miR-194-5p inhibits cell proliferation, migration and invasion in breast cancer by regulating the Wnt/β-catenin signaling pathway |
Q94600244 | Mitochondrial DNA alterations may influence the cisplatin responsiveness of oral squamous cell carcinoma |
Q46445017 | Oxysterol-Binding Protein-Related Protein 8 Inhibits Gastric Cancer Growth Through Induction of ER Stress, Inhibition of Wnt Signaling, and Activation of Apoptosis |
Q33754809 | Sulfiredoxin May Promote Cervical Cancer Metastasis via Wnt/β-Catenin Signaling Pathway |
Q47328865 | The role and mechanism of β‑arrestins in cancer invasion and metastasis (Review). |
Q95728213 | Wnt Signaling: A Potential Therapeutic Target in Head and Neck Squamous Cell Carcinoma |
Search more.